Zakia Sefsafi Brahim El Hasbaoui Amina Kili Aomar Agadr Mohammed Khattab
10.11604/pamj.2018.29.75.12353
Pan Afr Med J
2018 Jan 25;29:75.
macrophage activation syndrome t cells cytokines griscelli syndrome type 2 haemophagocytosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/29875956/
Immunologic Deficiency Syndromes / complications Lymphohistiocytosis, Hemophagocytic / complications Macrophage Activation Syndrome / etiology Piebaldism / complications rab27 GTP-Binding Proteins / genetics
Immunologic Deficiency Syndromes / complications Lymphohistiocytosis, Hemophagocytic / complications Macrophage Activation Syndrome / etiology Piebaldism / complications rab27 GTP-Binding Proteins / genetics Case Reports Review Adrenal Cortex Hormones / therapeutic use Child, Preschool Humans Immunologic Deficiency Syndromes / diagnosis Immunologic Deficiency Syndromes / physiopathology Immunosuppressive Agents / therapeutic use Lymphohistiocytosis, Hemophagocytic / diagnosis Lymphohistiocytosis, Hemophagocytic / physiopathology Macrophage Activation Syndrome / diagnosis Macrophage Activation Syndrome / physiopathology Male Mutation Piebaldism / diagnosis Piebaldism / physiopathology Primary Immunodeficiency Diseases Sepsis / etiology Adrenal Cortex Hormones Immunosuppressive Agents rab27 GTP-Binding Proteins RAB27A protein, human Griscelli syndrome type 2
PMC5987098
29875956
Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature
2018